STOCK TITAN

[8-K] Edible Garden AG Incorporated Warrant Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

On 30 Jul 2025, InspireMD, Inc. (NSPR) director Dr. Gary S. Roubin reported an open-market purchase of 41,322 common shares at $2.42 per share under a private-placement exemption (Securities Act §4(a)(2)). Following the transaction, the director’s directly held position increased to 608,425 shares. No derivative securities were involved, and the filing contains no sales or dispositions.

The single transaction represents an insider adding to his stake rather than trimming holdings, which can be viewed as a signal of personal confidence in the company’s prospects. The form was signed on 01 Aug 2025 by attorney-in-fact Craig Shore.

Il 30 luglio 2025, il direttore di InspireMD, Inc. (NSPR), Dr. Gary S. Roubin, ha comunicato un acquisto sul mercato aperto di 41.322 azioni ordinarie al prezzo di 2,42 $ per azione, effettuato in base a un'esenzione per collocamento privato (Securities Act §4(a)(2)). Dopo la transazione, la posizione detenuta direttamente dal direttore è salita a 608.425 azioni. Non sono stati coinvolti strumenti derivati e la comunicazione non riporta vendite o cessioni.

Questa singola operazione rappresenta un aumento della partecipazione da parte di un insider, anziché una riduzione, e può essere interpretata come un segnale di fiducia personale nelle prospettive dell’azienda. Il modulo è stato firmato il 1° agosto 2025 dall’avvocato delegato Craig Shore.

El 30 de julio de 2025, el director de InspireMD, Inc. (NSPR), Dr. Gary S. Roubin, reportó una compra en mercado abierto de 41,322 acciones ordinarias a $2.42 por acción bajo una exención de colocación privada (Securities Act §4(a)(2)). Tras la transacción, la posición directa del director aumentó a 608,425 acciones. No se involucraron valores derivados y la presentación no incluye ventas ni disposiciones.

Esta única transacción representa que un insider incrementa su participación en lugar de reducirla, lo cual puede interpretarse como una señal de confianza personal en las perspectivas de la compañía. El formulario fue firmado el 1 de agosto de 2025 por el apoderado Craig Shore.

2025년 7월 30일, InspireMD, Inc. (NSPR)의 이사 Dr. Gary S. Roubin사설 배정 면제(Securities Act §4(a)(2))에 따라 주당 $2.4241,322주 보통주장외 시장에서 매입했다고 보고했습니다. 거래 후 이사의 직접 보유 지분608,425주로 증가했습니다. 파생 증권은 포함되지 않았으며, 제출 서류에는 매도 또는 처분 내용이 없습니다.

이번 단일 거래는 내부자가 보유 지분을 줄이지 않고 오히려 늘린 것으로, 회사의 전망에 대한 개인적인 신뢰의 신호로 볼 수 있습니다. 해당 서류는 2025년 8월 1일 대리인 Craig Shore에 의해 서명되었습니다.

Le 30 juillet 2025, le directeur d’InspireMD, Inc. (NSPR), Dr Gary S. Roubin, a déclaré un achat sur le marché libre de 41 322 actions ordinaires au prix de 2,42 $ par action dans le cadre d’une exemption de placement privé (Securities Act §4(a)(2)). Suite à cette opération, la position détenue directement par le directeur est passée à 608 425 actions. Aucun titre dérivé n’était impliqué et le dossier ne contient aucune vente ou cession.

Cette transaction unique représente un renforcement de la participation par un initié, plutôt qu’une réduction, ce qui peut être interprété comme un signe de confiance personnelle dans les perspectives de l’entreprise. Le formulaire a été signé le 1er août 2025 par le mandataire Craig Shore.

Am 30. Juli 2025 meldete der Direktor von InspireMD, Inc. (NSPR), Dr. Gary S. Roubin, einen Offenmarkt-Kauf von 41.322 Stammaktien zu je 2,42 $ im Rahmen einer Privatplatzierungsausnahme (Securities Act §4(a)(2)). Nach der Transaktion erhöhte sich die direkt gehaltene Position des Direktors auf 608.425 Aktien. Es waren keine Derivate beteiligt, und die Meldung enthält keine Verkäufe oder Veräußerungen.

Die einzelne Transaktion zeigt, dass ein Insider seine Beteiligung aufstockt, anstatt sie zu reduzieren, was als persönliches Vertrauenssignal in die Zukunftsaussichten des Unternehmens gewertet werden kann. Das Formular wurde am 1. August 2025 vom bevollmächtigten Anwalt Craig Shore unterzeichnet.

Positive
  • Insider buy: Director acquired 41,322 shares, signalling confidence.
  • Increased ownership: Beneficial stake rose to 608,425 shares, fully held directly.
Negative
  • None.

Insights

TL;DR: Director bought 41k NSPR shares at $2.42, boosting holdings to 608k; positive insider signal, modest size.

The Form 4 shows a straightforward purchase with no accompanying sales, suggesting the director is increasing exposure rather than diversifying out. While the 41,322-share block is relatively small versus market float, insider buys—particularly from board members—often align with perceived undervaluation or upcoming milestones. The lack of derivative positions removes complexity and indicates direct balance-sheet commitment. Investors typically view such purchases favorably, though the filing alone does not disclose strategic catalysts or fundamental data.

Il 30 luglio 2025, il direttore di InspireMD, Inc. (NSPR), Dr. Gary S. Roubin, ha comunicato un acquisto sul mercato aperto di 41.322 azioni ordinarie al prezzo di 2,42 $ per azione, effettuato in base a un'esenzione per collocamento privato (Securities Act §4(a)(2)). Dopo la transazione, la posizione detenuta direttamente dal direttore è salita a 608.425 azioni. Non sono stati coinvolti strumenti derivati e la comunicazione non riporta vendite o cessioni.

Questa singola operazione rappresenta un aumento della partecipazione da parte di un insider, anziché una riduzione, e può essere interpretata come un segnale di fiducia personale nelle prospettive dell’azienda. Il modulo è stato firmato il 1° agosto 2025 dall’avvocato delegato Craig Shore.

El 30 de julio de 2025, el director de InspireMD, Inc. (NSPR), Dr. Gary S. Roubin, reportó una compra en mercado abierto de 41,322 acciones ordinarias a $2.42 por acción bajo una exención de colocación privada (Securities Act §4(a)(2)). Tras la transacción, la posición directa del director aumentó a 608,425 acciones. No se involucraron valores derivados y la presentación no incluye ventas ni disposiciones.

Esta única transacción representa que un insider incrementa su participación en lugar de reducirla, lo cual puede interpretarse como una señal de confianza personal en las perspectivas de la compañía. El formulario fue firmado el 1 de agosto de 2025 por el apoderado Craig Shore.

2025년 7월 30일, InspireMD, Inc. (NSPR)의 이사 Dr. Gary S. Roubin사설 배정 면제(Securities Act §4(a)(2))에 따라 주당 $2.4241,322주 보통주장외 시장에서 매입했다고 보고했습니다. 거래 후 이사의 직접 보유 지분608,425주로 증가했습니다. 파생 증권은 포함되지 않았으며, 제출 서류에는 매도 또는 처분 내용이 없습니다.

이번 단일 거래는 내부자가 보유 지분을 줄이지 않고 오히려 늘린 것으로, 회사의 전망에 대한 개인적인 신뢰의 신호로 볼 수 있습니다. 해당 서류는 2025년 8월 1일 대리인 Craig Shore에 의해 서명되었습니다.

Le 30 juillet 2025, le directeur d’InspireMD, Inc. (NSPR), Dr Gary S. Roubin, a déclaré un achat sur le marché libre de 41 322 actions ordinaires au prix de 2,42 $ par action dans le cadre d’une exemption de placement privé (Securities Act §4(a)(2)). Suite à cette opération, la position détenue directement par le directeur est passée à 608 425 actions. Aucun titre dérivé n’était impliqué et le dossier ne contient aucune vente ou cession.

Cette transaction unique représente un renforcement de la participation par un initié, plutôt qu’une réduction, ce qui peut être interprété comme un signe de confiance personnelle dans les perspectives de l’entreprise. Le formulaire a été signé le 1er août 2025 par le mandataire Craig Shore.

Am 30. Juli 2025 meldete der Direktor von InspireMD, Inc. (NSPR), Dr. Gary S. Roubin, einen Offenmarkt-Kauf von 41.322 Stammaktien zu je 2,42 $ im Rahmen einer Privatplatzierungsausnahme (Securities Act §4(a)(2)). Nach der Transaktion erhöhte sich die direkt gehaltene Position des Direktors auf 608.425 Aktien. Es waren keine Derivate beteiligt, und die Meldung enthält keine Verkäufe oder Veräußerungen.

Die einzelne Transaktion zeigt, dass ein Insider seine Beteiligung aufstockt, anstatt sie zu reduzieren, was als persönliches Vertrauenssignal in die Zukunftsaussichten des Unternehmens gewertet werden kann. Das Formular wurde am 1. August 2025 vom bevollmächtigten Anwalt Craig Shore unterzeichnet.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_____________________________________

 

FORM 8-K

_____________________________________

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 29, 2025

_____________________________________

 

EDIBLE GARDEN AG INCORPORATED

(Exact name of registrant as specified in its charter)

_____________________________________

 

Delaware

001-41371

85-0558704

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

283 County Road 519, Belvidere, New Jersey

 

07823

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (908) 750-3953

_____________________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

EDBL

The Nasdaq Stock Market LLC

Warrants to purchase Common Stock

EDBLW

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 3.03. Material Modification to Rights of Security Holders.

 

As previously disclosed, on May 14, 2025, Edible Garden AG Incorporated (the “Company”) issued shares of its Series B Preferred Stock to Streeterville Capital, LLC (“Streeterville”) as part of a transaction in which the Company acquired certain sustainable aquaculture assets located in Fort Dodge, Iowa and Streeterville invested additional capital into the Company. The terms of the Series B Preferred Stock were established under a certificate of designation accepted for filing by the Secretary of State of the State of Delaware on May 14, 2025 (the “Original Certificate”). As previously disclosed, shares of Series B Preferred Stock were entitled to cast a number of votes equal to 9.99% of the Company’s outstanding common stock, calculated on a fully diluted basis, with all other classes and series voting with the common stock, at any meeting of stockholders (the “Voting Rights”), as long as the Company confirmed with the staff of The Nasdaq Stock Market LLC (“Nasdaq”) that such Voting Rights were permissible.

 

After having consulted with Nasdaq, on July 28, 2025, the Company’s Board of Directors and Streeterville, as the sole holder of Series B Preferred Stock, approved an amended and restated certificate of designation (the “Updated Certificate”) to memorialize the Voting Rights in compliance with Nasdaq listing standards. The holder of Series B Preferred Stock will be entitled to cast a number of votes equal to the lesser of (i) 1,305,483 shares of common stock and (ii) 9.99% of the Company’s outstanding common stock, calculated on a fully diluted basis, with all other classes and series voting with the common stock, at any meeting of stockholders. This administrative change, along with ministerial conforming changes, represents the only reason for the Updated Certificate.

 

Except as clarified by the Updated Certificate, the terms of the Original Certificate remain in full force and effect as described in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 14, 2025, which description is incorporated herein by reference.

 

The Updated Certificate was accepted for filing by the Secretary of State of the State of Delaware on July 29, 2025. A copy of the Updated Certificate is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

To the extent required by Item 5.03 of Form 8-K, the information contained in Item 3.03 of this Current Report is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.

 

Description

3.1

 

Amended and Restated Certificate of Designation of Series B Preferred Stock, filed July 29, 2025.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

EDIBLE GARDEN AG INCORPORATED

 

 

Date: August 1, 2025

/s/ James E. Kras 

 

Name:

James E. Kras

 

 

Title:

President and Chief Executive Officer

 

 

 

3

 

FAQ

How many InspireMD (NSPR) shares did Dr. Gary S. Roubin purchase?

He bought 41,322 common shares.

At what price were the NSPR shares acquired?

The purchase price was $2.42 per share.

What is the director's total ownership after the transaction?

Dr. Roubin now directly owns 608,425 InspireMD shares.

Was the transaction a purchase or a sale?

It was a purchase; no shares were sold.

Did the Form 4 include any derivative security transactions?

No, the filing reports no derivative securities acquired or disposed.
EDIBLE GARDEN AG INC

NASDAQ:EDBLW

EDBLW Rankings

EDBLW Latest News

EDBLW Latest SEC Filings

EDBLW Stock Data

2.56M
Farm Products
Consumer Defensive
Link
United States
BELVIDERE